Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion type Assertion NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_head.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_provenance.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion evidence source_evidence_literature NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_provenance.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion SIO_000772 7545221 NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_provenance.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion wasDerivedFrom befree-20150227 NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_provenance.
- NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_assertion wasGeneratedBy ECO_0000203 NP544773.RA9g0OQopxnw_U8lvNxiz5M9K3mq80dwXqa1iGra5e08I130_provenance.